GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Total Stockholders Equity

Embecta (FRA:JX7) Total Stockholders Equity : €-708 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Total Stockholders Equity?

Embecta's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €-708 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Embecta's Book Value per Share for the quarter that ended in Mar. 2024 was €-12.28. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Embecta's Debt-to-Equity for the quarter that ended in Mar. 2024 was -2.13.

Embecta Total Stockholders Equity Historical Data

The historical data trend for Embecta's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Total Stockholders Equity Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Total Stockholders Equity
- 485.63 505.16 -900.31 -769.93

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -768.31 -747.08 -769.93 -727.64 -708.03

Embecta  (FRA:JX7) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Embecta's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-708.032-0)/57.6614
=-12.28

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Embecta's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(12.144 + 1492.792) / -708.032
=-2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embecta Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Embecta's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Total Stockholders Equity
Comparable Companies
LMAT ATRI BLFS OSUR ANIK UTMD WRBY ANGO PLSE SMTI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
EMBC:USA JX7:Germany
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Website
https://www.embecta.com
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines